This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Csl Behring Lengnau Ag. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Chee Kin Andrew Low: Innovator in Recombinant Protein Technology
Introduction
Chee Kin Andrew Low is a notable inventor based in Victoria, Australia. He has made significant contributions to the field of biotechnology, particularly in the area of recombinant proteins. His work focuses on enhancing the production and efficacy of these proteins, which have important applications in medicine and research.
Latest Patents
Chee Kin Andrew Low holds a patent titled "Media for the expression of recombinant vitamin K-dependent proteins." This invention relates to a method for increasing the activity and/or yield of a recombinant vitamin K-dependent protein expressed in cell culture. The patent also covers various uses and compositions of matter associated with this technology. He has 1 patent to his name.
Career Highlights
Chee Kin Andrew Low is currently employed at CSL Behring Lengnau AG, a leading global biotechnology company. His role involves research and development aimed at improving therapeutic proteins. His innovative approach has positioned him as a key player in the advancement of recombinant protein technologies.
Collaborations
Throughout his career, Chee Kin Andrew Low has collaborated with several talented individuals, including Yih Yean Lee and Campbell Douglas Aitken. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.
Conclusion
Chee Kin Andrew Low is a distinguished inventor whose work in recombinant protein technology has the potential to impact various fields, including medicine and biotechnology. His contributions continue to advance the understanding and application of these vital proteins.